1.125
Schlusskurs vom Vortag:
$1.16
Offen:
$1.15
24-Stunden-Volumen:
36,598
Relative Volume:
0.28
Marktkapitalisierung:
$49.96M
Einnahmen:
$18.89M
Nettoeinkommen (Verlust:
$-20.44M
KGV:
-1.4282
EPS:
-0.7877
Netto-Cashflow:
$-46.69M
1W Leistung:
+0.00%
1M Leistung:
+4.67%
6M Leistung:
+66.42%
1J Leistung:
-34.88%
Elutia Inc Stock (ELUT) Company Profile
Firmenname
Elutia Inc
Sektor
Branche
Telefon
240-247-1143
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ELUT
Elutia Inc
|
1.13 | 51.28M | 18.89M | -20.44M | -46.69M | -0.7877 |
|
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
312.11 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
77.83 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.84 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.75 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Eingeleitet | Cowen | Outperform |
| 2020-11-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-11-02 | Eingeleitet | Truist | Buy |
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Elutia Stock Flat Ahead of Open as $1.5 Billion Decision Waits - Bez Kabli
Elutia Inc. (ELUT) Dips 3.33% as Stock Hovers Near Critical $1.10 SupportRevenue Growth Stocks - Newser
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching - GlobeNewswire
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Moves HigherPro Trader Picks - Newser
Elutia (ELUT) Q1 2026 Earnings Miss by Significant: Key TakeawaysEarnings Season Preview - Newser
Elutia (ELUT) Q1 2026 Results: Profit Pressure, Guidance CutPost-Earnings Reaction - Newser
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Sahm
ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1.5B market - TradingView
Is Elutia (ELUT) Overvalued After Q1 2026? EPS Not Disclosed; Re - GuruFocus
Elutia (ELUT) Q1 2026 Earnings Transcript - AOL.com
Elutia (NASDAQ: ELUT) posts wider Q1 2026 loss while holding $28.5M cash - Stock Titan
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-05-15 - Seeking Alpha
Elutia Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Elutia to Present at the 16th Annual LD Micro Invitational on May 18th - Sahm
Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Ad - GuruFocus
Number of shareholders of Elutia, Inc. – NASDAQ:ELUT - TradingView
Transcript : Elutia Inc., Q1 2026 Earnings Call, May 14, 2026 - marketscreener.com
ELUT: Q1 2026 delivered revenue growth, margin gains, and strategic progress toward NXT-41x launch - TradingView
Elutia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Elutia’s Q1 2026 earnings miss EPS, revenue exceeds forecast - Investing.com
Elutia earnings missed by $0.02, revenue topped estimates - Investing.com Canada
Elutia Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Elutia 1Q Loss $7.47M >ELUT - Moomoo
Elutia reports Q1 results, expects FDA clearance for NXT-41 By Investing.com - Investing.com South Africa
Elutia : Presentation (ELUT Earning Call 14May26 Final) - marketscreener.com
Elutia reports Q1 results, expects FDA clearance for NXT-41 - Investing.com
ELUTIA ($ELUT) Releases Q1 2026 Earnings - Quiver Quantitative
Elutia to detail tech to curb infections after breast cancer reconstruction - Stock Titan
Elutia (NASDAQ: ELUT) Q1 loss deepens while NXT-41 pipeline and margins progress - Stock Titan
Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Elutia Reports First Quarter 2026 Results and Highlights - GlobeNewswire
Elutia to Present at the 16th Annual LD Micro Invitational May 18th - TMX Newsfile
Elutia (ELUT) Steady at $$1.04 — Awaiting Next Catalyst 2026-05-14Profitability Factor - Newser
TradingKey - TradingKey
ELUTIA INC (ELUT) Eps Diluted (TTM) - Zacks Investment Research
Earnings Preview: Elutia to Report Financial Results Post-market on May 14 - Moomoo
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - The Manila Times
ELUT Elutia delivers blowout Q4 2025 EPS results, yet shares fall 1.83% in post-earnings trading.PEG Ratio - newser.com
What factors are influencing Elutia (ELUT) stock | Q4 2025: EPS Beats ForecastsStock Market Community - newser.com
Elutia (ELUT) Stock Movers | Q4 2025: EPS Tops ViewsTurnaround Phase - Cổng thông tin điện tử tỉnh Lào Cai
ELUT (Elutia Inc.) posts a profitable Q4 2025 EPS result that far exceeds Wall Street’s consensus loss estimates. - Xã Thanh Hà
Elutia (NASDAQ: ELUT) seeks approval for larger equity plan and board slate - Stock Titan
[ARS] ELUTIA INC. SEC Filing - Stock Titan
Elutia (ELUT) Stock Volume Cluster (Smart Money Exits) 2026-04-20Correlation Analysis - Cổng thông tin điện tử tỉnh Lào Cai
ELUT (Elutia) delivers blowout Q4 2025 EPS results, with its stock price unchanged in trading today.Guidance vs Actual - Newser
Boston Scientific buys Elutia's bioenvelope business for $88 million - MSN
Elutia (ELUT) director receives 6,250 shares as RSUs vest, holding 125,000 - Stock Titan
Elutia Inc. (NASDAQ:ELUT) Q4 2025 earnings call transcript - MSN
Aug Retail: Is Elutia Inc forming a breakout patternTrend Reversal & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Quarterly Risk: Can Elutia Inc be recession proofWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
Finanzdaten der Elutia Inc-Aktie (ELUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elutia Inc-Aktie (ELUT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| NEELS GUIDO J | Director |
Jan 30 '26 |
Buy |
1.04 |
20,000 |
20,800 |
118,750 |
| NEELS GUIDO J | Director |
Jan 29 '26 |
Buy |
1.06 |
15,000 |
15,900 |
98,750 |
| NEELS GUIDO J | Director |
Jan 28 '26 |
Buy |
1.06 |
15,000 |
15,900 |
83,750 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):